OMAR TANWEER

Concepts (273)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Embolization, Therapeutic
16
2024
605
3.360
Why?
Hematoma, Subdural, Chronic
7
2024
10
3.150
Why?
Thrombectomy
16
2024
167
2.440
Why?
Bone Screws
8
2015
86
2.200
Why?
Atlanto-Axial Joint
8
2015
26
1.900
Why?
Meningeal Arteries
8
2024
12
1.890
Why?
Tinnitus
2
2023
39
1.670
Why?
Stroke
16
2024
1049
1.500
Why?
Intracranial Aneurysm
8
2022
130
1.480
Why?
Endovascular Procedures
9
2024
471
1.310
Why?
Stents
11
2024
999
1.070
Why?
Cranial Sinuses
2
2023
24
1.060
Why?
Neurosurgical Procedures
6
2020
633
1.010
Why?
Cervical Vertebrae
2
2015
219
0.890
Why?
Cerebral Revascularization
3
2023
25
0.850
Why?
Constriction, Pathologic
7
2023
322
0.820
Why?
Drainage
2
2016
462
0.800
Why?
Spinal Fusion
7
2018
150
0.710
Why?
Brain Ischemia
5
2023
311
0.700
Why?
Treatment Outcome
43
2024
33737
0.670
Why?
Cervical Atlas
2
2016
21
0.650
Why?
Cerebral Hemorrhage
4
2023
190
0.620
Why?
Joint Instability
3
2013
78
0.620
Why?
Vertebral Artery
3
2014
33
0.610
Why?
Angioplasty
4
2024
83
0.600
Why?
Craniotomy
3
2016
304
0.590
Why?
Non-alcoholic Fatty Liver Disease
1
2022
444
0.540
Why?
Arthrodesis
2
2015
15
0.540
Why?
Hematoma, Subdural
1
2016
30
0.530
Why?
Tranexamic Acid
1
2016
23
0.530
Why?
Neurosurgery
2
2014
117
0.520
Why?
Antifibrinolytic Agents
1
2016
39
0.520
Why?
Orthopedic Procedures
1
2015
145
0.450
Why?
Anticoagulants
3
2023
775
0.450
Why?
Spinal Injuries
1
2013
37
0.440
Why?
Retrospective Studies
34
2024
39890
0.440
Why?
Aneurysm, Ruptured
2
2015
44
0.440
Why?
Arachnoid
2
2023
14
0.430
Why?
Carotid Artery Diseases
1
2014
176
0.420
Why?
Propensity Score
3
2024
772
0.410
Why?
Humans
75
2024
270740
0.400
Why?
Prostheses and Implants
1
2014
294
0.390
Why?
Heparin
1
2013
342
0.380
Why?
Congenital Abnormalities
1
2014
280
0.370
Why?
Betacoronavirus
3
2020
514
0.370
Why?
Middle Aged
38
2024
90352
0.370
Why?
Aneurysm, False
1
2012
140
0.370
Why?
Arteries
1
2012
291
0.370
Why?
Aged
33
2024
73333
0.360
Why?
Spinal Cord
2
2021
718
0.350
Why?
Vascular Diseases
1
2012
235
0.350
Why?
Middle Cerebral Artery
3
2021
113
0.340
Why?
Aged, 80 and over
19
2024
30998
0.320
Why?
Evidence-Based Medicine
1
2014
1034
0.320
Why?
Coronavirus Infections
3
2020
625
0.310
Why?
Surgeons
1
2015
491
0.310
Why?
Venous Thromboembolism
1
2013
376
0.310
Why?
Male
41
2024
128315
0.310
Why?
Pneumonia, Viral
3
2020
700
0.300
Why?
Female
42
2024
148940
0.290
Why?
Subarachnoid Hemorrhage
2
2022
101
0.290
Why?
Registries
6
2024
2211
0.290
Why?
Blood Vessel Prosthesis
3
2020
368
0.290
Why?
Delivery of Health Care
1
2014
855
0.280
Why?
Angiography
2
2020
350
0.260
Why?
Tomography, X-Ray Computed
6
2024
7783
0.240
Why?
Reperfusion
2
2020
25
0.230
Why?
Carotid Artery, Internal
3
2024
81
0.220
Why?
Blood Coagulation Disorders
1
2024
115
0.210
Why?
Moyamoya Disease
1
2023
42
0.210
Why?
Vasospasm, Intracranial
1
2022
24
0.210
Why?
Balloon Embolectomy
2
2018
2
0.210
Why?
Skull
3
2023
251
0.200
Why?
Fetal Stem Cells
2
2012
5
0.200
Why?
Drug-Eluting Stents
1
2023
77
0.200
Why?
Adult
18
2023
82040
0.200
Why?
Intracranial Arteriosclerosis
1
2021
14
0.200
Why?
Maternal-Fetal Exchange
2
2012
90
0.200
Why?
Urinary Retention
1
2021
21
0.190
Why?
Central Nervous System Vascular Malformations
1
2021
24
0.190
Why?
Ischemic Attack, Transient
1
2021
66
0.190
Why?
Arterial Occlusive Diseases
1
2022
149
0.190
Why?
Pregnancy Complications, Cardiovascular
2
2012
109
0.190
Why?
Temporal Arteries
1
2021
43
0.180
Why?
New York City
4
2021
75
0.180
Why?
Brain Infarction
1
2020
36
0.180
Why?
Hemangioma, Cavernous, Central Nervous System
1
2020
23
0.180
Why?
Pons
1
2020
54
0.180
Why?
Radiology, Interventional
1
2021
142
0.180
Why?
Product Surveillance, Postmarketing
1
2020
43
0.180
Why?
Carotid Stenosis
1
2021
159
0.170
Why?
Empirical Research
1
2019
10
0.170
Why?
Infectious Disease Transmission, Patient-to-Professional
1
2020
59
0.170
Why?
Time-to-Treatment
4
2024
307
0.170
Why?
Comprehensive Health Care
1
2020
48
0.170
Why?
Arteriovenous Malformations
1
2020
65
0.170
Why?
Fibrinolytic Agents
1
2022
293
0.170
Why?
Spinal Cord Diseases
1
2020
88
0.160
Why?
Pandemics
4
2021
1610
0.160
Why?
Arteriovenous Fistula
1
2020
101
0.160
Why?
Skull Base
2
2020
225
0.160
Why?
Cerebrovascular Disorders
1
2019
153
0.160
Why?
Catheters
3
2024
133
0.160
Why?
Delivery of Health Care, Integrated
1
2020
165
0.150
Why?
Biomechanical Phenomena
2
2018
279
0.150
Why?
Thrombolytic Therapy
1
2020
250
0.150
Why?
Hyperglycemia
1
2020
337
0.150
Why?
Spinal Diseases
1
2018
131
0.140
Why?
Lumbar Vertebrae
1
2018
247
0.140
Why?
Quality Indicators, Health Care
1
2020
354
0.140
Why?
Neuroendoscopy
1
2016
35
0.140
Why?
Nervous System Neoplasms
1
2016
35
0.130
Why?
Epidermal Cyst
1
2016
47
0.130
Why?
Intracranial Arteriovenous Malformations
1
2016
42
0.130
Why?
Dermoid Cyst
1
2016
39
0.130
Why?
Finite Element Analysis
1
2016
54
0.130
Why?
Radiosurgery
2
2016
1383
0.130
Why?
Blood Glucose
1
2020
1269
0.130
Why?
Confidence Intervals
2
2014
749
0.130
Why?
Epilepsy
2
2016
931
0.130
Why?
Carotid-Cavernous Sinus Fistula
1
2015
9
0.130
Why?
Models, Anatomic
1
2016
146
0.120
Why?
Vascular Access Devices
1
2015
48
0.120
Why?
Health Personnel
1
2020
652
0.120
Why?
Tuberous Sclerosis
1
2016
145
0.120
Why?
Vascular Patency
1
2015
189
0.120
Why?
Printing, Three-Dimensional
1
2016
145
0.120
Why?
Hydrocephalus
1
2016
259
0.110
Why?
Computer-Assisted Instruction
1
2014
85
0.110
Why?
Cadaver
1
2013
202
0.110
Why?
Osteoarthritis, Spine
1
2012
1
0.110
Why?
Time Factors
5
2024
13006
0.110
Why?
Quality Improvement
1
2020
914
0.110
Why?
Physician's Role
1
2015
230
0.100
Why?
Patients
1
2015
246
0.100
Why?
Thrombosis
1
2018
743
0.100
Why?
Alberta
2
2023
67
0.100
Why?
Braces
1
2012
14
0.100
Why?
Data Collection
1
2015
608
0.100
Why?
Arachnoid Cysts
1
2012
13
0.100
Why?
Sex Distribution
1
2013
497
0.100
Why?
Brain Neoplasms
2
2022
4958
0.100
Why?
Case-Control Studies
1
2022
6224
0.100
Why?
Glioblastoma
1
2022
1776
0.100
Why?
Age Distribution
1
2013
727
0.100
Why?
Coronary Artery Disease
1
2018
884
0.100
Why?
Hypothalamic Diseases
1
2012
42
0.100
Why?
Glioma
1
2022
1978
0.100
Why?
Thoracic Vertebrae
1
2012
200
0.090
Why?
Hamartoma
1
2012
90
0.090
Why?
Terminology as Topic
1
2013
418
0.090
Why?
Wounds and Injuries
1
2015
437
0.090
Why?
Hospitalization
2
2020
2167
0.090
Why?
Patient Acceptance of Health Care
1
2016
600
0.090
Why?
Vagus Nerve Stimulation
1
2011
63
0.090
Why?
Radiography
1
2014
1986
0.090
Why?
Combined Modality Therapy
2
2024
9039
0.080
Why?
Abnormalities, Multiple
1
2016
1023
0.080
Why?
Young Adult
5
2016
22251
0.080
Why?
Imaging, Three-Dimensional
1
2014
909
0.080
Why?
Pilot Projects
1
2016
2828
0.080
Why?
Clinical Trials as Topic
1
2020
3844
0.080
Why?
Risk
1
2013
1939
0.080
Why?
Myocardial Ischemia
1
2012
421
0.080
Why?
Attitude of Health Personnel
1
2015
901
0.080
Why?
Education, Medical, Graduate
1
2014
705
0.070
Why?
Severity of Illness Index
2
2020
4372
0.070
Why?
Preoperative Care
1
2014
1567
0.070
Why?
Neoplasms
1
2014
15927
0.070
Why?
Pain
1
2015
1694
0.070
Why?
Cerebral Angiography
2
2018
148
0.070
Why?
Myocardium
1
2011
1232
0.070
Why?
Adolescent
4
2016
32767
0.060
Why?
Prevalence
1
2013
3404
0.060
Why?
Infarction, Anterior Cerebral Artery
1
2024
3
0.060
Why?
Stem Cell Transplantation
1
2012
1418
0.060
Why?
Vertebrobasilar Insufficiency
1
2024
7
0.060
Why?
Child
6
2016
30559
0.060
Why?
Cell Movement
1
2011
2472
0.060
Why?
Myocardial Infarction
1
2011
1181
0.060
Why?
Polymethyl Methacrylate
1
2023
41
0.050
Why?
Cerebral Infarction
1
2023
72
0.050
Why?
Anterior Cerebral Artery
1
2022
8
0.050
Why?
Intention to Treat Analysis
1
2022
122
0.050
Why?
Internship and Residency
1
2014
1452
0.050
Why?
Dilatation
1
2022
87
0.050
Why?
Walruses
1
2021
1
0.050
Why?
Paraparesis
1
2021
15
0.050
Why?
Intracranial Hemorrhages
1
2022
120
0.050
Why?
Platelet Aggregation Inhibitors
1
2024
327
0.050
Why?
Carotid Artery, Common
1
2021
93
0.050
Why?
Anesthesia, General
1
2022
222
0.050
Why?
Treatment Failure
1
2024
1430
0.050
Why?
Retreatment
1
2022
448
0.050
Why?
United States
2
2020
15861
0.050
Why?
Vasodilator Agents
1
2022
230
0.050
Why?
Cell Differentiation
1
2011
4116
0.050
Why?
Cranial Fossa, Posterior
1
2020
50
0.050
Why?
Cerebral Small Vessel Diseases
1
2020
11
0.040
Why?
Blood Sedimentation
1
2020
38
0.040
Why?
Constipation
1
2021
187
0.040
Why?
Fibrin Fibrinogen Degradation Products
1
2020
66
0.040
Why?
Troponin
1
2020
87
0.040
Why?
Radial Artery
1
2020
35
0.040
Why?
Causality
1
2020
176
0.040
Why?
Green Fluorescent Proteins
2
2012
693
0.040
Why?
Thrombophilia
1
2020
55
0.040
Why?
Prone Position
1
2020
59
0.040
Why?
Personal Protective Equipment
1
2020
63
0.040
Why?
Critical Pathways
1
2020
160
0.040
Why?
Aphasia
1
2018
19
0.040
Why?
Operating Rooms
1
2020
128
0.040
Why?
Disease Models, Animal
1
2012
7381
0.040
Why?
Workflow
1
2020
279
0.040
Why?
Biomarkers
2
2020
5051
0.040
Why?
Patient Admission
1
2020
231
0.040
Why?
Postoperative Complications
1
2014
5681
0.040
Why?
Monitoring, Intraoperative
1
2020
264
0.040
Why?
Cytoreduction Surgical Procedures
1
2022
510
0.040
Why?
Range of Motion, Articular
1
2018
107
0.040
Why?
Patient Positioning
1
2020
196
0.040
Why?
Endoscopy
1
2020
496
0.040
Why?
Prospective Studies
2
2023
13414
0.040
Why?
Neuroimaging
1
2020
401
0.030
Why?
Ultrasonography
1
2023
1933
0.030
Why?
Feasibility Studies
1
2021
2353
0.030
Why?
Brain
2
2022
4208
0.030
Why?
Patient Care Team
1
2020
823
0.030
Why?
Recovery of Function
1
2018
681
0.030
Why?
Magnetic Resonance Imaging
2
2021
7895
0.030
Why?
Graft Occlusion, Vascular
1
2015
112
0.030
Why?
Cerebral Arteries
1
2015
100
0.030
Why?
Patient Care Planning
1
2016
303
0.030
Why?
Comorbidity
1
2020
2394
0.030
Why?
Risk Factors
2
2020
17888
0.030
Why?
Zygapophyseal Joint
1
2012
14
0.030
Why?
Neck Pain
1
2012
41
0.030
Why?
Recurrence
1
2020
4878
0.020
Why?
CDX2 Transcription Factor
1
2011
35
0.020
Why?
Animals
4
2021
61956
0.020
Why?
Follow-Up Studies
2
2018
15218
0.020
Why?
Cohort Studies
1
2024
9470
0.020
Why?
Headache
1
2012
175
0.020
Why?
Mice, Inbred Strains
1
2011
563
0.020
Why?
Disease Progression
1
2022
6867
0.020
Why?
Infant
2
2016
13999
0.020
Why?
Data Interpretation, Statistical
1
2012
483
0.020
Why?
Incidence
1
2020
5824
0.020
Why?
Muscle, Smooth, Vascular
1
2011
329
0.020
Why?
Vision Disorders
1
2012
242
0.020
Why?
Fluorescent Antibody Technique
1
2012
1121
0.020
Why?
Child, Preschool
2
2016
17061
0.020
Why?
Diagnosis, Differential
1
2018
4831
0.020
Why?
In Vitro Techniques
1
2011
1697
0.020
Why?
Models, Animal
1
2011
657
0.020
Why?
Pregnancy
2
2012
8130
0.020
Why?
Calcinosis
1
2012
426
0.020
Why?
Reoperation
1
2012
1392
0.020
Why?
Anticonvulsants
1
2011
430
0.020
Why?
Endothelium, Vascular
1
2011
879
0.020
Why?
Survival Rate
1
2020
12541
0.020
Why?
Myocytes, Cardiac
1
2011
704
0.020
Why?
Homeodomain Proteins
1
2011
1125
0.020
Why?
Flow Cytometry
1
2012
3045
0.020
Why?
Electroencephalography
1
2011
991
0.020
Why?
Longitudinal Studies
1
2011
2057
0.020
Why?
Biopsy
1
2012
3484
0.010
Why?
Mice, Transgenic
1
2011
4223
0.010
Why?
Cells, Cultured
1
2011
5694
0.010
Why?
Infant, Newborn
1
2016
8699
0.010
Why?
Mice, Inbred C57BL
1
2012
7100
0.010
Why?
Mice
2
2012
35600
0.010
Why?
Transcription Factors
1
2011
5438
0.010
Why?
TANWEER's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (273)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_